Posted inNews and Updates
Digital Check-ins Boost Cancer Treatment Success
New research shows that simple digital check-ins significantly improve cancer treatment outcomes and patient quality of life. Learn how remote monitoring works.
Posted inNews and Updates
FDA Regulatory Shifts: New Trends in Clinical Trial Models
Discover how new FDA transparency standards, protocol-centric recruitment, and Medical Affairs integration are reshaping the future of clinical trials.
Posted inNews and Updates
Serina Therapeutics Advances Phase Ib Trial for SER-252
Serina Therapeutics completes sentinel dosing for SER-252 in its Phase Ib trial. Learn how this innovative polymer-drug conjugate aims to improve treatment.
Posted inNews and Updates
GSK Partner Hansoh Pharma Achieves Phase III SCLC Success
GSK and Hansoh Pharma report success in a Chinese Phase III trial for a new SCLC antibody-drug conjugate, marking a major leap in targeted lung cancer care.
Posted inNews and Updates
New Targeted Therapy Shows Promise for GNAQ/GNA11 Melanoma
New Phase 1 trial results reveal a novel inhibitor targeting GNAQ and GNA11-mutant melanomas, marking a major step forward in precision cancer therapy.
Posted inNews and Updates
Clinical Trial Disruptions: How CRO Mergers Impact Sites
Discover how mid-study CRO mergers create operational risks for clinical sites, from payment delays to staff turnover, and how to protect your trial data.
Posted inNews and Updates
Lecanemab Autoinjector Shows Bioequivalence to IV Infusion
New clinical data confirms lecanemab’s subcutaneous autoinjector is bioequivalent to IV infusion, promising a simpler treatment path for Alzheimer’s patients.
Posted inNews and Updates
Digital Twins in Clinical Trials: Innovation vs. Validation
Digital twins offer to revolutionize clinical trials, but regulatory validation challenges may hinder their progress. Explore the impact on medical research.
Posted inNews and Updates
FDA Raises Concerns Over Orviglance Clinical Data
The FDA has raised clinical objections regarding image-reading protocols for the liver contrast agent Orviglance. Learn what this means for the drug's future.
Posted inNews and Updates
Maharashtra FDA Halts Sale of Two Cadila Pharmaceuticals Drugs
Maharashtra FDA has banned two Cadila Pharmaceuticals drugs due to branding concerns. Learn how this regulatory move aims to prevent medication errors.